Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 May;67(5):1550–1560. doi: 10.1172/JCI110186

Vitamin D plasma binding protein. Turnover and fate in the rabbit.

J G Haddad, D R Fraser, D E Lawson
PMCID: PMC370724  PMID: 6894454

Abstract

The metabolic disposition of the plasma binding protein (DBP) for vitamin D and its metabolites was studied in adult rabbits. Apo-DBP was purified from rabbit plasma and enzymatically labeled with radioiodine. The radioiodine-labeled protein retained its ability to bind vitamin D sterols and its physicochemical properties. When 125I-labeled DBP and 131I-labeled rabbit albumin were simultaneously injected intravenously, the 125I was cleared from plasma at a faster rate (t 1/2 = 1.7 d) than 131I (t 1/2 = 5 d) and 125I was present in excess of 131I in kidney, liver, skeletal muscle, heart, lung, intestine, testis, and bone 1 h after injection. In contrast to DBP, 25(OH)D3 was cleared more slowly (t 1/2 = 10.7 d). Compared to albumin, DBP radioactivity appeared earlier and in greater quantity in the urine of catheterized rabbits. Gel filtration analyses of plasma revealed most of the 125I to elute in the position of DBP, with only small amounts in the less than 1,000-dalton region. In contrast, almost all of the urine 125I eluted in this small molecular weight fraction. The molar ratio of DBP to 25(OH)D3 in normal rabbit plasma was 138/1. The extravascular pool of DBP was calculated to be 1.5-2.4 times larger than the intravascular DBP pool, and the molar replacement rate of DBP was 1,350-fold higher than that of 25(OH)D3. The plasma disappearance curves of holo-DBP, prepared either by saturating with 25(OH)D3 or by covalently linking 3 beta-bromoacetoxy-25(OH)D3, were very similar to that of apo-DBP. Neuraminidase treatment of DBP did not alter its plasma survival. These studies indicate that DBP or DBP-25(OH)D3 complex is removed from plasma by a variety of tissues, that the DBP moiety is degraded during this process, and that a significant recirculation of 25(OH)D3 probably occurs. The molar excess of DBP to 25(OH)D3 in plasma, and the relatively rapid turnover of DBP indicate that a high capacity, high affinity, and dynamic transport mechanism for vitamin D sterols exists in rabbit plasma.

Full text

PDF
1550

Images in this article

1553Image
on p.1553

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashwell G., Morell A. G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974;41(0):99–128. doi: 10.1002/9780470122860.ch3. [DOI] [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Balsan S., Garabedian M. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets. J Clin Invest. 1972 Apr;51(4):749–759. doi: 10.1172/JCI106869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bec P., Bayard F., Louvet J. P. 25-Hydroxycholecalciderol dynamics in human plasma. Rev Eur Etud Clin Biol. 1972 Oct;17(8):793–796. [PubMed] [Google Scholar]
  5. Botham K. M., Tanaka Y., DeLuca H. F. 25-Hydroxyvitamin D3-1-hydroxylase. Inhibition in vitro by rat and pig tissues. Biochemistry. 1974 Nov 19;13(24):4961–4966. doi: 10.1021/bi00721a014. [DOI] [PubMed] [Google Scholar]
  6. Bouillon R., Van Baelen H., Rombauts W., De Moor P. The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem. 1976 Jul 1;66(2):285–291. doi: 10.1111/j.1432-1033.1976.tb10518.x. [DOI] [PubMed] [Google Scholar]
  7. Bouillon R., Van Baelen H., Rombauts W., de Moor P. The isolation and characterization of the vitamin D-binding protein from rat serum. J Biol Chem. 1978 Jun 25;253(12):4426–4431. [PubMed] [Google Scholar]
  8. Bouillon R., van Baelen H., de Moor P. The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab. 1977 Aug;45(2):225–231. doi: 10.1210/jcem-45-2-225. [DOI] [PubMed] [Google Scholar]
  9. Chen T. L., Hirst M. A., Feldman D. A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem. 1979 Aug 25;254(16):7491–7494. [PubMed] [Google Scholar]
  10. Cleve H., Patutschnick W. Neuraminidase treatment reveals sialic acid differences in certain genetic variants of the Gc system (vitamin-D-binding protein). Hum Genet. 1979 Mar 12;47(2):193–198. doi: 10.1007/BF00273201. [DOI] [PubMed] [Google Scholar]
  11. Cleve H. The variants of the group-specific component. A review of their distribution in human populations. Isr J Med Sci. 1973 Sep-Oct;9(9):1133–1146. [PubMed] [Google Scholar]
  12. Cooke N. E., Walgate J., Haddad J. G., Jr Human serum binding protein for vitamin D and its metabolites. I. Physicochemical and immunological identification in human tissues. J Biol Chem. 1979 Jul 10;254(13):5958–5964. [PubMed] [Google Scholar]
  13. Cooke N. E., Walgate J., Haddad J. G., Jr Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue. J Biol Chem. 1979 Jul 10;254(13):5965–5971. [PubMed] [Google Scholar]
  14. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  15. Dottavio-Martin D., Ravel J. M. Radiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride. Anal Biochem. 1978 Jul 1;87(2):562–565. doi: 10.1016/0003-2697(78)90706-6. [DOI] [PubMed] [Google Scholar]
  16. Eastwood J. B., de Wardener H. E., Gray R. W., Lemann J. L., Jr Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia. Lancet. 1979 Jun 30;1(8131):1377–1378. doi: 10.1016/s0140-6736(79)92012-9. [DOI] [PubMed] [Google Scholar]
  17. Frolik C. A., DeLuca H. F. Metabolism of 1,25-dihydroxycholecalciferol in the rat. J Clin Invest. 1972 Nov;51(11):2900–2906. doi: 10.1172/JCI107114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ghazarian J. G., Kream B., Botham K. M., Nickells M. W., DeLuca H. F. Rat plasma 25-hydroxyvitamin D3 binding protein: an inhibitor of the 25-hydroxyvitamin D3-1alpha-hydroxylase. Arch Biochem Biophys. 1978 Jul;189(1):212–220. doi: 10.1016/0003-9861(78)90134-0. [DOI] [PubMed] [Google Scholar]
  19. Goldstein J. L., Anderson R. G., Brown M. S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature. 1979 Jun 21;279(5715):679–685. doi: 10.1038/279679a0. [DOI] [PubMed] [Google Scholar]
  20. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  21. Gray R. W., Caldas A. E., Wilz D. R., Lemann J., Jr, Smith G. A., DeLuca H. F. Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults. J Clin Endocrinol Metab. 1978 May;46(5):756–765. doi: 10.1210/jcem-46-5-756. [DOI] [PubMed] [Google Scholar]
  22. Haddad J. G., Chyu K. J. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971 Dec;33(6):992–995. doi: 10.1210/jcem-33-6-992. [DOI] [PubMed] [Google Scholar]
  23. Haddad J. G., Hillman L., Rojanasathit S. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1976 Jul;43(1):86–91. doi: 10.1210/jcem-43-1-86. [DOI] [PubMed] [Google Scholar]
  24. Haddad J. G., Jr, Walgate J. 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem. 1976 Aug 25;251(16):4803–4809. [PubMed] [Google Scholar]
  25. Haddad J. G., Jr, Walgate J. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest. 1976 Nov;58(5):1217–1222. doi: 10.1172/JCI108575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hughes M. R., Haussler M. R. 1,25-Dihydroxyvitamin D3 receptors in parathyroid glands. Preliminary characterization of cytoplasmic and nuclear binding components. J Biol Chem. 1978 Feb 25;253(4):1065–1073. [PubMed] [Google Scholar]
  27. Imawari M., Goodman D. S. Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum. J Clin Invest. 1977 Mar;59(3):432–442. doi: 10.1172/JCI108657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Imawari M., Kida K., Goodman D. S. The transport of vitamin D and its 25-hydroxy metabolite in human plasma. Isolation and partial characterization of vitamin D and 25-hydroxyvitamin D binding protein. J Clin Invest. 1976 Aug;58(2):514–523. doi: 10.1172/JCI108495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Katz J., Rostami H., Dunn A. Evaluation of glucose turnover, body mass and recycling with reversible and irreversible tracers. Biochem J. 1974 Jul;142(1):161–170. doi: 10.1042/bj1420161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lawson D. E., Wilson P. W. Intranuclear localization and receptor proteins for 1,25-dihydroxycholecalciferol in chick intestine. Biochem J. 1974 Dec;144(3):573–583. doi: 10.1042/bj1440573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Liao S. Cellular receptors and mechanisms of action of steroid hormones. Int Rev Cytol. 1975;41:87–172. doi: 10.1016/s0074-7696(08)60967-5. [DOI] [PubMed] [Google Scholar]
  32. MUNRO H. N., DOWNIE E. D. RELATIONSHIP OF LIVER COMPOSITION TO INTENSITY OF PROTEIN METABOLISM IN DIFFERENT MAMMALS. Nature. 1964 Aug 8;203:603–604. doi: 10.1038/203603a0. [DOI] [PubMed] [Google Scholar]
  33. Mawer E. B., Backhouse J., Davies M., Hill L. F., Taylor C. M. Metabolic fate of administered 1,25-dihydroxycholecalciferol in controls and in patients with hypoparathyroidism. Lancet. 1976 Jun 5;1(7971):1203–1206. doi: 10.1016/s0140-6736(76)92157-7. [DOI] [PubMed] [Google Scholar]
  34. Mawer E. B., Backhouse J., Holman C. A., Lumb G. A., Stanbury S. W. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972 Sep;43(3):413–431. doi: 10.1042/cs0430413. [DOI] [PubMed] [Google Scholar]
  35. Miyachi Y., Vaitukaitis J. L., Nieschlag E., Lipsett M. B. Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab. 1972 Jan;34(1):23–28. doi: 10.1210/jcem-34-1-23. [DOI] [PubMed] [Google Scholar]
  36. Muto Y., Smith J. E., Milch P. O., Goodman D. S. Regulation of retinol-binding protein metabolism by vitamin A status in the rat. J Biol Chem. 1972 Apr 25;247(8):2542–2550. [PubMed] [Google Scholar]
  37. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. II. Prog Allergy. 1962;6:30–154. doi: 10.1159/000313795. [DOI] [PubMed] [Google Scholar]
  38. Omdahl J. L., Jelinek G., Eaton R. P. Kinetic analysis of 25-hydroxyvitamin D3 metabolism in strontium-induced rickets in the chick. J Clin Invest. 1977 Nov;60(5):1202–1210. doi: 10.1172/JCI108873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. PRUNIER J. H., BEARN A. G., CLEVE H. SITE OF FORMATION OF THE GROUP-SPECIFIC COMPONENT AND CERTAIN OTHER SERUM PROTEINS. Proc Soc Exp Biol Med. 1964 Apr;115:1005–1007. doi: 10.3181/00379727-115-29101. [DOI] [PubMed] [Google Scholar]
  40. Rojanasathit S., Haddad J. G. Ontogeny and effect of vitamin D deprivation on rat serum 25-hydroxyvitamin D binding protein. Endocrinology. 1977 Mar;100(3):642–647. doi: 10.1210/endo-100-3-642. [DOI] [PubMed] [Google Scholar]
  41. Smith J. E., Goodman D. S. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest. 1971 Oct;50(10):2159–2167. doi: 10.1172/JCI106710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Svasti J., Bowman B. H. Human group-specific component. Changes in electrophoretic mobility resulting from vitamin D binding and from neuraminidase digestion. J Biol Chem. 1978 Jun 25;253(12):4188–4194. [PubMed] [Google Scholar]
  43. THOMAS W. C., Jr, MORGAN H. G., CONNOR T. B., HADDOCK L., BILLS C. E., HOWARD J. E. Studies of antiricketic activity in sera from patients with disorders of calcium metabolism and preliminary observations on the mode of transport of vitamin D in human serum. J Clin Invest. 1959 Jul;38(7):1078–1085. doi: 10.1172/JCI103884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tsai H. C., Norman A. W. Studies on calciferol metabolism. 8. Evidence for a cytoplasmic receptor for 1,25-dihydroxy-vitamin D3 in the intestinal mucosa. J Biol Chem. 1973 Sep 10;248(17):5967–5975. [PubMed] [Google Scholar]
  45. Van Baelen H., Bouillon R., De Moor P. Binding of 25-hydroxycholecalciferol in tissues. J Biol Chem. 1977 Apr 25;252(8):2515–2518. [PubMed] [Google Scholar]
  46. Van Baelen H., Bouillon R., De Moor P. The heterogeneity of human Gc-globulin. J Biol Chem. 1978 Sep 25;253(18):6344–6345. [PubMed] [Google Scholar]
  47. Van Baelen H., Bouillon R., De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem. 1980 Mar 25;255(6):2270–2272. [PubMed] [Google Scholar]
  48. Warren J. C., Mueller J. R. Labeling of steroid systems. Methods Enzymol. 1977;46:447–460. doi: 10.1016/s0076-6879(77)46054-3. [DOI] [PubMed] [Google Scholar]
  49. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  50. Youngdahl-Turner P., Rosenberg L. E., Allen R. H. Binding and uptake of transcobalamin II by human fibroblasts. J Clin Invest. 1978 Jan;61(1):133–141. doi: 10.1172/JCI108911. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES